1Bays H. Sodium glucose co-transporter type 2(SGLT-2)inhibitors: Targeting the kidney to improve glycemic control in diabetes mellitus[J]. Diabetes Ther, 2013, 4(2): 195-220.
2Rahmoune H, Thompson PW, Ward JM, et al. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes[J]. Diabetes, 2005, 54(12): 3427- 3434.
3Hardman TC, Rutherford P, Dubrey SW, et al. Sodium-glucose co- transporter 2 inhibitors: from apple tree to 'Sweet Pee'[J]. Curt Pharm Des, 2010, 16(34): 3830-3838.
4Santer R, Calado J. Familial renal glucosuria and SGLT-2: from a mendelian trait to a therapeutic target[J]. Clin J Am Soc Nephrol, 2010, 5(1): 133-141.
5Mitrakou A. Kidney: its impact on glucose homeostasis and hormonal regulation[J]. Diabetes Res Clin Pract, 2011, 93(Suppl 1): S66-S72.
6Mather A, Pollock C. Glucose handling by the kidney[J]. Kidney Int Suppl, 2011, (120): S1-S6.
7Mogensen CE. Maximum tubular reabsorption capacity for glucose and renal hemodynamcis during rapid hypertonic glucose infusion in normal and diabetic subjects[J]. Scand J Clin Lab Invest, 1971, 28(1): 101-109.
8DeFronzo RA, Davids0n JA, Del Prato S. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia[J]. Diabetes Obes Metab, 2012, 14(1): 5-14.
9Macdonald FR, Peel JE, Jones HB, et al. The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats[J]. Diabetes Obes Metab, 2010, 12(11): 1004-1012.
10Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients[J]. J Clin Invest, 2014, 124(2): 499-508.
二级参考文献5
1Neumiller JJ, White JR, Campbell RK. Sodium-glucose cotransport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus[J]. Drugs,2010,70(4) :377-385.
2A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999[J]. Diabet Med,1999,16(9):716-730.
3Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE comprehensive diabetes management algorithm 2013[J]. Endocr Pract,2013,19(2) : 327-336.
4List JF, Woo V, Morales E, et al. Sodium-glucose co-transport inhibition with dapagliflozin in type 2 diabetes [J]. Diabetes Care, 2009,32 (4) : 650-657.
5Ferrannini E, Ramos SJ, Salsali A, et al. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial[J]. Diabetes Care, 2010, 33 (10) :2217-2224.
